Details of the Drug Combinations

General Information of This Drug (ID: DMOUC09)

Drug Name
Norepinephrine   DMOUC09
Synonyms
norepinephrine; L-Noradrenaline; Levarterenol; 51-41-2; L-Norepinephrine; Levophed; (-)-Norepinephrine; L-arterenol; (R)-Noradrenaline; (R)-Norepinephrine; Levonor; Levonorepinephrine; Adrenor; Aktamin; Levonoradrenaline; Sympathin E; (R)-(-)-Norepinephrine; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; Noradrenalin; Norepirenamine; norepinephrinum; Noradrenalinum; Levoarterenol; Norartrinal; Nor-Epirenan; L-3,4-dihydroxyphenylethanolamine; Levarterenolo; Noreinefrina; Norepinefrina; Norepinephrinum; Levarterenolo [DCIT]; Nor adrenalin; Noradrenalina [Italian]; Norepinephrine Noradrenalin; LT03330026; ALBB-006229; Nor adrenalin (TN); Noradrenaline (JP15); Noreinefrina [INN-Spanish]; Norepinephrine (INN); Norepinephrine [INN:JAN]; Norepinephrinum [INN-Latin]; Norepinephrine l-Tartrate (1:1); D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; (-)-(R)-Norepinephrine; (-)-Arterenol free base; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; Ecteinascidins
Indication
Disease Entry ICD 11 Status REF
Alopecia ED70 Approved [1]
Bronchiectasis CA24 Approved [1]
Bronchitis CA20 Approved [1]
Chronic fatigue syndrome 8E49 Approved [1]
Depression 6A70-6A7Z Approved [1]
Psychosexual disorder N.A. Approved [1]
Pulmonary emphysema CA21.Z Approved [1]
Pure autonomic failure N.A. Approved [1]
Radiodermatitis N.A. Approved [1]
Sepsis 1G40-1G41 Approved [2]
Severe asthma CA23 Approved [1]
Asthma CA23 Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Vasoconstrictor Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

6 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Dobutamine + Norepinephrine DC26UOZ Dobutamine Optimal Tissue Perfusion [3]
Norepinephrine + Terlipressin DCE22ZE Terlipressin Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS [4]
Oxytocin + Norepinephrine DCN6TM6 Oxytocin Postpartum Hemorrhage [5]
Norepinephrine + Phenylephrine DC2SEXK Phenylephrine Hypotension [6]
Epinephrine + Norepinephrine DCCG2C2 Epinephrine Shock [7]
Norepinephrine + Propofol DC28T66 Propofol Hemodynamic Instability [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DrugCom(s)

References

1 Norepinephrine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 505).
3 ClinicalTrials.gov (NCT03288051) Effects of Intraoperative, Goal-directed Crystalloid vs. Colloid Fluid Resuscitation on Free Flaps
4 ClinicalTrials.gov (NCT01637454) TYPE 2 HEPATORENAL SYNDROME
5 ClinicalTrials.gov (NCT06285396) Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study
6 ClinicalTrials.gov (NCT03215797) Phenylephrine or Norepinephrine for a Better Hemodynamic Stability
7 ClinicalTrials.gov (NCT02118467) Vasoactive Drugs in Intensive Care Unit
8 ClinicalTrials.gov (NCT03864094) Hemodynamics During Induction of General Anesthesia After Prophylactic Ephedrine, Phenylephrine or Norepinephrine.